Pharmacy Times Continuing Education™ (PTCE)’s Post

Check out this head-to head comparison of the humanized NSG-SGM3 model vs Taconic's NOG-Exl model at U Penn! If you are working in oncology research and have been experiencing difficulties due to early myeloid hyperactivation syndrome (MCH) in your in-vivo models, I would love to connect with you and discuss how Taconic can support your studies long-term!

New paper compares the humanized NSG-SGM3 and NOG-EXL showing better outcomes and more translatable results for glioblastoma work. Read more: https://hubs.li/Q02PpxY10 #oncology

Join my colleagues from Inizio Medical for a webinar on June 27th where we will dive into the most talked-about topics from #ASCO24, provide in-depth analysis, and highlight key takeaways - this is not to be missed! Learn more and register here: https://lnkd.in/e3pr9aEG #MRX #ResearchPartnership #Oncology #Webinar

Thinking of submitting an abstract for #JADPROLive before the July 1 deadline? Take advantage of #APSHO AP Academy’s course: Abstract Development 101! Learn how to craft compelling abstracts by identifying potential abstract categories, understanding the purpose behind abstracts, and using expert tips to avoid common pitfalls. https://lnkd.in/gNUk4An9 #Oncology #Abstract #APCareSafeCare

Thought it would be interesting to take the ADC trial data from Beacon and visualise it over time. If this is well received I might do something similar on how ADC targets and payloads have changed over the years. In the meantime, we're running an ADC webinar later today, which you can register for here: https://ter.li/rzae33 #ADCs #Oncology

👉 Watch this video made by FLASH Radiotherapy & Particle Therapy - FRPT to discover how to work on an abstract and get some tips.   #FRPT2024 #Oncology #FLASHrt

We're happy to share that Tomasz Jankowski, MD, PhD, the presenting author of MAIA’s poster at #ASCO24 and the key investigator in MAIA's Phase 2 #clinicaltrial, was selected as one of the very few authors to provide a video update. Watch Dr. Jankowski’s discussion about the progress of THIO-101 here: https://bit.ly/3RExJja #ClinicalResearch #Oncology #NSCLC

ELCC 2024 wrapped up over the weekend and we’ve compiled the latest post-conference insights, highlighting the top trials as discussed by leading oncologists on X. 🌟 Learn more about LARVOL CLIN and explore our key insights here: https://bit.ly/3TTUFwc. #ELCC2024 #LARVOL #Oncology #Research

In this episode of #OncLiveOnAir, Dr Halmos discusses common AEs associated with the ADCs that are used in #NSCLC and ways to manage and mitigate these toxicities. #oncology #lcsm https://lnkd.in/emj5Guz8

Really looking forward to this, off the back of the recent Nature Medicine article - come join us to learn more about the DigiONE pilot, federated analytics to get patient level data equivalent insights and what is ahead